 Toan Ong
Concepts (111)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Medical Record Linkage | 5 | 2024 | 68 | 2.180 |
Why?
| | Influenza, Human | 13 | 2026 | 635 | 1.790 |
Why?
| | Influenza Vaccines | 13 | 2026 | 553 | 1.790 |
Why?
| | Hospitalization | 32 | 2026 | 2293 | 1.520 |
Why?
| | Emergency Service, Hospital | 23 | 2025 | 2251 | 1.330 |
Why?
| | Electronic Health Records | 5 | 2024 | 1144 | 0.920 |
Why?
| | Ambulatory Care | 10 | 2025 | 598 | 0.890 |
Why?
| | Immunization, Secondary | 4 | 2022 | 92 | 0.840 |
Why?
| | Population Surveillance | 3 | 2025 | 485 | 0.790 |
Why?
| | Algorithms | 3 | 2024 | 1791 | 0.650 |
Why?
| | Heart Defects, Congenital | 4 | 2020 | 886 | 0.630 |
Why?
| | Child Abuse | 1 | 2024 | 549 | 0.560 |
Why?
| | Referral and Consultation | 1 | 2024 | 822 | 0.560 |
Why?
| | Data Mining | 1 | 2017 | 117 | 0.500 |
Why?
| | Pregnancy Complications, Infectious | 3 | 2025 | 416 | 0.480 |
Why?
| | Mass Screening | 1 | 2024 | 1325 | 0.460 |
Why?
| | United States | 28 | 2026 | 15447 | 0.440 |
Why?
| | Adult | 40 | 2026 | 39715 | 0.440 |
Why?
| | Adolescent | 32 | 2026 | 22326 | 0.430 |
Why?
| | Medical Informatics | 1 | 2014 | 99 | 0.390 |
Why?
| | Humans | 60 | 2026 | 142526 | 0.370 |
Why?
| | Seasons | 8 | 2026 | 554 | 0.370 |
Why?
| | Vaccination | 13 | 2025 | 1479 | 0.360 |
Why?
| | Biomedical Research | 2 | 2017 | 692 | 0.350 |
Why?
| | Outpatients | 3 | 2022 | 425 | 0.330 |
Why?
| | Case-Control Studies | 10 | 2026 | 3604 | 0.300 |
Why?
| | Young Adult | 19 | 2026 | 13878 | 0.290 |
Why?
| | Influenza A Virus, H1N1 Subtype | 3 | 2025 | 153 | 0.280 |
Why?
| | Influenza A Virus, H3N2 Subtype | 5 | 2026 | 49 | 0.270 |
Why?
| | Middle Aged | 22 | 2026 | 35049 | 0.270 |
Why?
| | Aged | 18 | 2026 | 25117 | 0.260 |
Why?
| | Critical Illness | 2 | 2023 | 857 | 0.250 |
Why?
| | Vaccines, Combined | 5 | 2023 | 49 | 0.250 |
Why?
| | Aged, 80 and over | 9 | 2025 | 8020 | 0.250 |
Why?
| | Research Design | 3 | 2025 | 1113 | 0.240 |
Why?
| | Female | 28 | 2026 | 76624 | 0.240 |
Why?
| | Male | 26 | 2026 | 70910 | 0.230 |
Why?
| | Child, Preschool | 10 | 2026 | 11634 | 0.230 |
Why?
| | Diabetes Mellitus, Type 2 | 4 | 2020 | 2561 | 0.230 |
Why?
| | RNA, Messenger | 8 | 2024 | 2828 | 0.220 |
Why?
| | Colorado | 4 | 2024 | 4638 | 0.220 |
Why?
| | Indiana | 1 | 2024 | 35 | 0.220 |
Why?
| | Vaccines, Synthetic | 5 | 2022 | 139 | 0.220 |
Why?
| | Child | 15 | 2026 | 22562 | 0.220 |
Why?
| | Respiratory Syncytial Virus Vaccines | 1 | 2024 | 38 | 0.210 |
Why?
| | Data Accuracy | 1 | 2024 | 63 | 0.210 |
Why?
| | Physical Abuse | 1 | 2024 | 39 | 0.210 |
Why?
| | Child Protective Services | 1 | 2024 | 64 | 0.200 |
Why?
| | Drug Prescriptions | 1 | 2025 | 274 | 0.200 |
Why?
| | Respiratory Syncytial Virus Infections | 1 | 2024 | 134 | 0.190 |
Why?
| | Infant | 7 | 2026 | 9908 | 0.190 |
Why?
| | Diabetes Mellitus, Type 1 | 4 | 2020 | 3819 | 0.190 |
Why?
| | Antiviral Agents | 2 | 2025 | 758 | 0.180 |
Why?
| | Viral Vaccines | 1 | 2023 | 107 | 0.180 |
Why?
| | Information Dissemination | 1 | 2023 | 210 | 0.170 |
Why?
| | Immunocompromised Host | 1 | 2021 | 206 | 0.160 |
Why?
| | India | 4 | 2020 | 214 | 0.150 |
Why?
| | Probability | 1 | 2020 | 307 | 0.150 |
Why?
| | Information Storage and Retrieval | 1 | 2020 | 120 | 0.150 |
Why?
| | Diabetic Ketoacidosis | 1 | 2020 | 210 | 0.130 |
Why?
| | Infant, Newborn | 3 | 2024 | 6324 | 0.130 |
Why?
| | Practice Patterns, Physicians' | 1 | 2025 | 1353 | 0.120 |
Why?
| | Comparative Effectiveness Research | 1 | 2017 | 164 | 0.120 |
Why?
| | Retrospective Studies | 5 | 2025 | 16626 | 0.120 |
Why?
| | Influenza B virus | 2 | 2026 | 45 | 0.120 |
Why?
| | Antibodies, Neutralizing | 3 | 2022 | 327 | 0.120 |
Why?
| | Databases, Factual | 2 | 2019 | 1458 | 0.110 |
Why?
| | Mental Disorders | 1 | 2024 | 1144 | 0.110 |
Why?
| | Hospital Mortality | 3 | 2023 | 952 | 0.110 |
Why?
| | Models, Theoretical | 1 | 2017 | 585 | 0.100 |
Why?
| | Antibodies, Monoclonal | 3 | 2022 | 1471 | 0.090 |
Why?
| | Registries | 4 | 2020 | 2227 | 0.090 |
Why?
| | Laboratories | 2 | 2021 | 106 | 0.080 |
Why?
| | Hospitals | 2 | 2024 | 690 | 0.070 |
Why?
| | Pregnancy | 3 | 2025 | 7113 | 0.070 |
Why?
| | Immunity, Herd | 1 | 2024 | 7 | 0.050 |
Why?
| | Respiratory Syncytial Virus, Human | 1 | 2024 | 81 | 0.050 |
Why?
| | Spermine | 1 | 2023 | 30 | 0.050 |
Why?
| | Propensity Score | 1 | 2025 | 343 | 0.050 |
Why?
| | RNA, Messenger, Stored | 1 | 2022 | 7 | 0.050 |
Why?
| | Stakeholder Participation | 1 | 2023 | 80 | 0.050 |
Why?
| | Advisory Committees | 1 | 2024 | 215 | 0.050 |
Why?
| | Patient Outcome Assessment | 1 | 2023 | 132 | 0.050 |
Why?
| | Vaccination Coverage | 1 | 2023 | 104 | 0.040 |
Why?
| | Treatment Failure | 1 | 2022 | 357 | 0.040 |
Why?
| | Risk Factors | 2 | 2025 | 10593 | 0.040 |
Why?
| | Insurance Claim Reporting | 1 | 2020 | 26 | 0.040 |
Why?
| | Computer Simulation | 1 | 2025 | 1018 | 0.040 |
Why?
| | Immunization Schedule | 1 | 2021 | 202 | 0.040 |
Why?
| | Morbidity | 1 | 2020 | 321 | 0.040 |
Why?
| | Logistic Models | 1 | 2025 | 2102 | 0.040 |
Why?
| | Patient Participation | 1 | 2023 | 430 | 0.040 |
Why?
| | Ambulatory Care Facilities | 1 | 2021 | 247 | 0.040 |
Why?
| | Demography | 1 | 2020 | 297 | 0.040 |
Why?
| | Bias | 1 | 2020 | 208 | 0.040 |
Why?
| | Age of Onset | 1 | 2020 | 545 | 0.030 |
Why?
| | Linear Models | 1 | 2019 | 857 | 0.030 |
Why?
| | Antibodies, Monoclonal, Humanized | 1 | 2022 | 917 | 0.030 |
Why?
| | Socioeconomic Factors | 1 | 2020 | 1319 | 0.030 |
Why?
| | Patient Readmission | 1 | 2021 | 703 | 0.030 |
Why?
| | Models, Statistical | 1 | 2019 | 677 | 0.030 |
Why?
| | Intensive Care Units | 1 | 2021 | 874 | 0.030 |
Why?
| | Cross-Sectional Studies | 1 | 2025 | 5700 | 0.030 |
Why?
| | Incidence | 1 | 2020 | 2826 | 0.020 |
Why?
| | Prevalence | 1 | 2019 | 2817 | 0.020 |
Why?
| | Cohort Studies | 1 | 2023 | 5858 | 0.020 |
Why?
| | Prognosis | 1 | 2020 | 4112 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2020 | 5270 | 0.020 |
Why?
| | Time Factors | 1 | 2022 | 7006 | 0.020 |
Why?
| | Obesity | 1 | 2022 | 3027 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2020 | 11298 | 0.010 |
Why?
|
|
Ong's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|